Anti-Procainamide [Clone PC10-131.1] - 1.0 mg
Procainamide is an antiarrhythmic used to treat cardiac arrhythmias. It induces rapid block of the batrachotoxin (BTX) -activated sodium channels of the heart muscle and acts as antagonist to long gating closures. Procainamide is metabolized via different pathways. The most common one is the acetylation of procainamide to the less toxic N- acetylprocainamide. Procainamide was approved by the US FDA on June 2, 1950.
Product Specifications
Target
Procainamide
Clone
PC10-131.1
Applications
ELISA
Field of Research
Drugs
Concentration
Lot Specific
Shipping Conditions
Next Day 2-8°C
Storage Conditions
This antibody is stable for at least one (1) year at -20°C to -70°C. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles.
Formulation
This monoclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.2 - 7.4 with no carrier protein or preservatives added.
Explore Other Products
Browse additional items from our catalog
Fam180a sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
THRAP3 sgRNA CRISPR Lentivector (Human) (Target 1)
